AI & ChatGPT searches , social queriess for STAMULUMAB
Search references for STAMULUMAB. Phrases containing STAMULUMAB
See searches and references containing STAMULUMAB!
Search references for STAMULUMAB. Phrases containing STAMULUMAB
See searches and references containing STAMULUMAB!STAMULUMAB
Monoclonal antibody
Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab
Stamulumab
Antibodies from clones of the same blood cell
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Monoclonal_antibody
Class of drugs
disable myostatin, including apitegromab, domagrozumab, landogrozumab, and stamulumab. Another form of myostatin inhibition is gene therapy. Another monoclonal
Myostatin_inhibitor
Monoclonal antibody against amyloid beta
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Donanemab
Monoclonal antibody against amyloid beta
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Lecanemab
Pharmaceutical drug
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Evolocumab
Mammalian and avian protein
the market. An antibody genetically engineered to neutralize myostatin, stamulumab, which was under development by pharmaceutical company Wyeth, is no longer
Myostatin
Chemical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Bococizumab
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Emicizumab
Drug class
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Anti-amyloid_antibodies
Naming scheme for assigning generic, or nonproprietary, names to monoclonal antibodies
Germany: John Wiley & Sons. p. 2131. ISBN 978-3-527-32937-3. Entry on Stamulumab. at: Römpp Online. Georg Thieme Verlag, retrieved 2021-11-17. AGN (1931)
Nomenclature of monoclonal antibodies
Nomenclature_of_monoclonal_antibodies
Chemical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Bimagrumab
Medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Marstacimab
Antibodies from non-human species made nearly identical with human ones
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Humanized_antibody
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Galcanezumab
Drugs that inhibit α-synuclein
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Anti-α-synuclein_drug
Experimental monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Prasinezumab
Human monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Denosumab
Pharmaceutical drug
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Romosozumab
SSKI stacofylline (INN) Stadol Stahist Stalevo 100 stallimycin (INN) stamulumab (INN, USAN) Stan-Gard Stanozide stanozolol (INN) Staphcillin Starjemza
List_of_drugs:_Sp–Sub
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
TGF_beta_1
Medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Concizumab
Medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Bevacizumab
Interleukin 36 receptor (IL1RL2/IL1RAP) Y generalized pustular psoriasis (GPP) Stamulumab mab human myostatin muscular dystrophy Sugemalimab mab human PD-1 non-small-cell
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Chemical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Caplacizumab
Pharmaceutical biological monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Fremanezumab
Veterinary medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Izenivetmab
Muscular degenerative disease of the face, shoulder blades, and upper arms
that calcium dysregulation played a part in muscle cell death. MYO-029 (stamulumab), an antibody that inhibits myostatin, was developed to promote muscle
Facioscapulohumeral muscular dystrophy
Facioscapulohumeral_muscular_dystrophy
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Etaracizumab
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Trevogrumab
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Bedinvetmab
Veterinary medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Relfovetmab
Medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Idarucizumab
Monoclonal antibody against amyloid beta
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Aducanumab
Monoclonal antibody designed to treat X-linked hypophosphatemia
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Burosumab
Monoclonal antibody protein
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Gantenerumab
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Abelacimab
Monoclonal antibody medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Solanezumab
Chemical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Erenumab
Mammalian protein found in Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Follistatin
Cytokine
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Transforming growth factor beta
Transforming_growth_factor_beta
Protein-coding gene in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
GDF15
Pharmaceutical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Abciximab
Regulators of feedback on FSH-production
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Activin_and_inhibin
Pharmaceutical drug
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Alirocumab
Mammalian protein found in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Anti-Müllerian_hormone
Chemical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Bapineuzumab
Pharmaceutical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Indium_(111In)_imciromab
American telethon
MDA Muscle Walk (US) Labor Day Telethon (defunct; US/Canada) Décrypthon (France) Grøn Koncert (Denmark) Clinical trials Stamulumab (MYO-029) Category
The Jerry Lewis MDA Labor Day Telethon
The_Jerry_Lewis_MDA_Labor_Day_Telethon
Protein family
found mutated. It also plays a role in non-MSI-H colorectal cancers. Stamulumab (MYO-029) myostatin Inhibitor Lee SJ, Reed LA, Davies MV, Girgenrath S
Activin_type_2_receptors
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Eptinezumab
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
TGF_beta_receptor_1
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
GDF7
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Fasinumab
Signaling pathway involving transforming growth factor beta proteins
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
TGF_beta_signaling_pathway
Group of growth factor proteins
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein_8B
Antibody tested against Alzheimer's
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Crenezumab
Pharmaceutical drug
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Ranibizumab
Family of proteins
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
SMAD_(protein)
Cellular process in embryonic development
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Nodal_signaling_pathway
Protein-coding gene in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
GDF11
Chemical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Tanezumab
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Inclacumab
Medication for macular degeneration
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Faricimab
Pharmaceutical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Amlenetug
Protein-coding gene in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
SMAD3
Anti-tau monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Semorinemab
Medication
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Bentracimab
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Evinacumab
Biomarker indicative of breast cancer patients' prognosis
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Transforming_growth_factor
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
GDF1
Pharmaceutical drug
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Ramucirumab
Protein family
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
TGF_beta_receptor
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein_6
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
GDF5
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
INHBA
Protein family
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Transforming growth factor beta superfamily
Transforming_growth_factor_beta_superfamily
Human protein and coding gene
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein_4
Mammalian protein found in Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
SMAD4
Protein found in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein_2
Monoclonal antibody
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Refanezumab
Pharmaceutical compound
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Devextinetug
Inhibitor protein in the TGF beta signaling pathway
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Gremlin_(protein)
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
BMPR2
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
GDF2
Protein found in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
SMAD2
Pharmaceutical drug
Burosumab Denosumab Humanized Blosozumab† Romosozumab Musculoskeletal Human Stamulumab† Circulatory Human Abelacimab Alirocumab Ascrinvacumab§ Bentracimab† Enoticumab
Brolucizumab
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
INHBB
Protein-coding gene in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Decorin
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein_3
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Poly(A)-specific_ribonuclease
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
TGFBR3
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
BAMBI
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
TGF_beta_receptor_2
Protein-coding gene in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Bone_morphogenetic_protein_15
Protein and coding gene in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
INHA
InterPro Family
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Chordin
Protein-coding gene in the species Homo sapiens
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
BMPR1B
Protein found in humans
Gremlin (Drm) LTBP1 Noggin TGIF Thrombospondin 1 (THBS1) Tomoregulin 1 Antibodies: Stamulumab (against myostatin) TRC105 (against endoglin) Others: Endoglin
Cerberus_(protein)
STAMULUMAB
STAMULUMAB
STAMULUMAB
STAMULUMAB
Boy/Male
American, Australian, Gujarati, Indian, Kannada
Light
Boy/Male
Gujarati, Hindu, Indian
Nectar
Surname or Lastname
English or Irish
English or Irish : variant of Searcy.
Girl/Female
Tamil
Girl/Female
French, German, Latin
From Sebastia
Girl/Female
Hindu, Indian, Marathi
Made of a Precious Metal
Surname or Lastname
English
English : occupational name for a transporter of goods, Middle English cartere, from an agent derivative of Middle English cart(e) or from Anglo-Norman French car(e)tier, a derivative of Old French caret (see Cartier). The Old French word coalesced with the earlier Middle English word cart(e) ‘cart’, which is from either Old Norse kartr or Old English cræt, both of which, like the Late Latin word, were probably originally derived from Celtic.Northern Irish : reduced form of McCarter.
Girl/Female
Assamese, Gujarati, Hindu, Indian, Kannada, Malayalam, Marathi, Sikh, Tamil, Telugu
Life; Water
Girl/Female
Muslim
Firm, Young girl
Girl/Female
Hindu, Indian
Joy; Delight; One of the Three Sons of Dharma
STAMULUMAB
STAMULUMAB
STAMULUMAB
STAMULUMAB
STAMULUMAB